Highlights
Profile claimed by owner
About
Redefining Relief for CRS Patients
SLATE Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) with SilexGel, a novel sol-gel hydrogel technology.
Its mission is to improve patients' quality of life through innovative and effective treatments. SilexGel is a cutting-edge platform technology designed for the systemic and localized delivery of therapeutics. Unlike drug-eluting implants that tend to migrate and cause side effects, or nasal sprays that offer short-term relief, SilexGel provides long-lasting effects with minimal side effects.
Identity
| Name | Slate Therapeutics |
|---|---|
| Slug | slate-therapeutics |
| Type / kind | startup |
| Source _id | LjW7YDIxtF1T8bTaszyH6OWzrVUBVkCPoS3NiNylZ5TmOz5Cg6KpqR |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv-Yafo, Israel |
Web & social
| Website | https://slatetherapeutics.com/ |
|---|---|
| https://www.linkedin.com/company/82163710 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryDrugs Discovery & Development
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatients
Business models
B2B2C
Tags
drug-deliveryhealthcaremedical-devicestreatmentsoral-drugs
Funding
| Total raised | $1.0M |
|---|---|
| Current stage | Pre-Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}